COVID-19

Ocuphire Appoints Rick Rodgers as Interim Chief Executive Officer

Seasoned operating executive with successful track record at late-stage biopharmaceutical companiesFARMINGTON HILLS, Mich., April 21, 2023 (GLOBE NEWSWIRE) -- Ocuphire…

1 year ago

XORTX Announces Receipt of FDA Orphan Drug Designation to Treat Autosomal Dominant Kidney Disease

CALGARY, Alberta, April 21, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX…

1 year ago

StateHouse Confirms Extension of Series A Debt Obligations to May 22nd, 2023

SAN DIEGO and TORONTO, April 21, 2023 (GLOBE NEWSWIRE) -- StateHouse Holdings Inc. ("StateHouse" or the "Company") (CSE: STHZ) (OTCQX:…

1 year ago

Baycrest’s Goal Management Training Now Offered Through Telus Health’s AbilitiCBT Platform

First large-scale digital roll out of Baycrest’s Goal Management Training will support mental rehabilitation for people across Canada and the…

1 year ago

SteraMist to Showcase Disinfection Technology at Multiple Tradeshows

FREDERICK, Md., April 20, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in…

1 year ago

United States Patent and Trademark Office (USPTO) Grants Evoke Pharma a Formulation Patent Covering GIMOTI

The Company Will Submit for FDA Orange-Book Listing in the Near TermSOLANA BEACH, Calif., April 20, 2023 (GLOBE NEWSWIRE) --…

1 year ago

Trinity Biotech Announces the $30 Million Sale of its Life Sciences Supply Business to Biosynth

DUBLIN, Ireland, April 20, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer…

1 year ago

Windtree Therapeutics Announces Pricing of Upsized $10.8 Million Underwritten Public Offering

WARRINGTON, Pa., April 20, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company…

1 year ago

Lisata Therapeutics Receives $2.2 Million of Non-Dilutive Capital Through New Jersey Technology Business Tax Certificate Transfer Program

BASKING RIDGE, N.J., April 20, 2023 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage…

1 year ago